These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36017673)

  • 1. Cost-effectiveness of implementing a digital psychosocial intervention for patients with psychotic spectrum disorders in low- and middle-income countries in Southeast Europe: Economic evaluation alongside a cluster randomised trial.
    Feng Y; Roukas C; Russo M; Repišti S; Džubur Kulenović A; Injac Stevović L; Konjufca J; Markovska-Simoska S; Novotni L; Ristić I; Smajić-Mešević E; Uka F; Zebić M; Vončina L; Bobinac A; Jovanović N
    Eur Psychiatry; 2022 Aug; 65(1):e56. PubMed ID: 36017673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving treatment of patients with psychosis in low-and-middle-income countries in Southeast Europe: Results from a hybrid effectiveness-implementation, pragmatic, cluster-randomized clinical trial (IMPULSE).
    Jovanović N; Russo M; Pemovska T; Francis JJ; Arenliu A; Bajraktarov S; Džubur Kulenović A; Injac Stevović L; Novotni A; Andrić Petrović S; Radojičić T; Ribić E; Konjufca J; Marić NP
    Eur Psychiatry; 2022 Aug; 65(1):e50. PubMed ID: 35946167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil.
    Aceituno D; Razzouk D; Jin H; Pennington M; Gadelha A; Bressan R; Noto C; Crossley N; Prina M;
    Epidemiol Psychiatr Sci; 2024 Apr; 33():e21. PubMed ID: 38576239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.
    Heslin M; Patel A; Stahl D; Gardner-Sood P; Mushore M; Smith S; Greenwood K; Onagbesan O; O'Brien C; Fung C; Ohlsen R; Hopkins D; Lowe P; Arbuthnot M; Mutatsa S; Todd G; Kolliakou A; Lally J; Stubbs B; Ismail K; David A; Murray R; Atakan Z; Gaughran F
    BMC Psychiatry; 2017 Dec; 17(1):407. PubMed ID: 29273021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of collaborative care for depression in UK primary care: economic evaluation of a randomised controlled trial (CADET).
    Green C; Richards DA; Hill JJ; Gask L; Lovell K; Chew-Graham C; Bower P; Cape J; Pilling S; Araya R; Kessler D; Bland JM; Gilbody S; Lewis G; Manning C; Hughes-Morley A; Barkham M
    PLoS One; 2014; 9(8):e104225. PubMed ID: 25121991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a community-delivered multicomponent intervention compared with enhanced standard care of obese adolescents: cost-utility analysis alongside a randomised controlled trial (the HELP trial).
    Panca M; Christie D; Cole TJ; Costa S; Gregson J; Holt R; Hudson LD; Kessel AS; Kinra S; Mathiot A; Nazareth I; Wataranan J; Wong ICK; Viner RM; Morris S
    BMJ Open; 2018 Feb; 8(2):e018640. PubMed ID: 29449292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial.
    Paganini S; Lin J; Kählke F; Buntrock C; Leiding D; Ebert DD; Baumeister H
    BMJ Open; 2019 Apr; 9(4):e023390. PubMed ID: 30967405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical- and cost-effectiveness of a technology-supported and solution-focused intervention (DIALOG+) in treatment of patients with chronic depression-study protocol for a multi-site, cluster randomised controlled trial [TACK].
    McNamee P; Matanov A; Jerome L; Kerry S; Walker N; Feng Y; Molodynski A; Scott S; Guruvaiah L; Collinson S; McCabe R; Geddes J; Priebe S; Bird V
    Trials; 2022 Mar; 23(1):237. PubMed ID: 35346348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a digital mental health intervention for individuals with psychosis - a multi-country qualitative study.
    Pemovska T; Arënliu A; Konjufca J; Uka F; Hunter J; Bajraktarov S; Stevović LI; Jerotić S; Kulenović AD; Novotni A; Novotni L; Radojičić T; Repišti S; Ribić E; Ristić I; Mešević ES; Zebić M; Jovanović N
    BMC Psychiatry; 2021 Sep; 21(1):468. PubMed ID: 34563145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived sustainability of psychosocial treatment in low- and middle-income countries in South-Eastern Europe.
    Ribic E; Sikira H; Dzubur Kulenovic A; Pemovska T; Russo M; Jovanovic N; Radojicic T; Repisti S; Milutinović M; Blazevska B; Konjufca J; Ramadani F; Jerotic S; Savic B
    BJPsych Open; 2022 Aug; 8(5):e156. PubMed ID: 35968901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC
    Li X; Bilcke J; van der Velden AW; Bruyndonckx R; Coenen S; Bongard E; de Paor M; Chlabicz S; Godycki-Cwirko M; Francis N; Aabenhus R; Bucher HC; Colliers A; De Sutter A; Garcia-Sangenis A; Glinz D; Harbin NJ; Kosiek K; Lindbæk M; Lionis C; Llor C; Mikó-Pauer R; Radzeviciene Jurgute R; Seifert B; Sundvall PD; Touboul Lundgren P; Tsakountakis N; Verheij TJ; Goossens H; Butler CC; Beutels P;
    Eur J Health Econ; 2023 Aug; 24(6):909-922. PubMed ID: 36131214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and cost-effectiveness of newborn home visits: findings from the Newhints cluster-randomised controlled trial in rural Ghana.
    Pitt C; Tawiah T; Soremekun S; ten Asbroek AH; Manu A; Tawiah-Agyemang C; Hill Z; Owusu-Agyei S; Kirkwood BR; Hanson K
    Lancet Glob Health; 2016 Jan; 4(1):e45-56. PubMed ID: 26639857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the effectiveness and cost-effectiveness of a solution-focused resource-orientated approach (DIALOG+) to improving the quality of life for people with psychosis in India and Pakistan-a cluster RCT.
    Bird VJ; Sajun SZ; Peppl R; Evans-Lacko S; Priebe S; Singh S; Venkatraman L; Ramachandran P; Pasha A; Malik A; Qureshi O
    Trials; 2023 Jan; 24(1):59. PubMed ID: 36703162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a structured intervention to make routine clinical meetings therapeutically effective (DIALOG+) for patients with depressive and anxiety disorders in Bosnia and Herzegovina: A cluster randomised controlled trial.
    Slatina Murga S; Janković S; Muhić M; Sikira H; Burn E; Priebe S; Džubur Kulenović A
    Psychiatry Res Commun; 2021 Dec; 1(2):None. PubMed ID: 35028649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.